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Background and aims: It is unknown whether socioeconomic status (SES) is a risk factor 
for hepatitis C virus (HCV) infection or a prognostic factor following infection.
Methods: From Danish nationwide registries, we obtained information on three markers of 
SES: employment, income, and education. In a case control design, we examined HCV infected 
patients and controls; conditional logistic regression was employed to obtain odds ratios (ORs) 
for HCV infection for each of the three SES markers, adjusting for the other two SES markers, 
comorbidity, and substance abuse. In a cohort design, we used Cox regression analysis to compute 
mortality rate ratios (MRRs) for each of the three SES markers, adjusting for the other two SES 
markers, comorbidity level, age, substance abuse, and gender.
Results: When compared to employed persons, ORs for HCV infection were 2.71 (95% 
confidence interval [CI]: 2.24–3.26) for disability pensioners and 2.24 (95% CI: 1.83–2.72) 
for the unemployed. When compared to persons with a high income, ORs were 1.64 (95% 
CI: 1.34–2.01) for low income persons and 1.19 (95% CI: 1.02–1.40) for medium income persons. 
The OR was 1.35 (95% CI: 1.20–1.52) for low education (no more than basic schooling). When 
compared to employed patients, MRRs were 1.71 (95% CI: 1.22–2.40) for unemployed patients 
and 2.24 (95% CI: 1.63–3.08) for disability pensioners. When compared to high income patients, 
MRRs were 1.47 (95% CI: 1.05–2.05) for medium income patients and 1.64 (95% CI: 1.13–2.34) 
for low income patients. Educational status was not associated with mortality.
Conclusion: Low SES was associated with an increased risk of HCV infection and with poor 
prognosis in HCV infected patients.
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Introduction
The hepatitis C virus (HCV) is a linear, single stranded RNA virus and was established 
as the cause of non-A, non-B hepatitis in 1989.1 With 170 million persons infected 
worldwide, HCV infection poses serious challenges to global health.2 HCV infection is 
primarily a hepatotropic virus, but the virus also infects cells of the lymphatic system.3 
Consequently, HCV infection is associated with substantial morbidity and mortality.4–10 
Nonetheless, when comparing mortality between HCV infected patient and the general 
population4,7,9 and between patients with chronic and cleared HCV infection,8,11,12 there 
seems to be a discrepancy in increased mortality. This could indicate that not only the 
virus, but that also other factors may increase mortality in HCV infected individuals, 
a hypothesis that is supported by an enormously increased mortality among patients 
with cleared HCV infection when compared to the general population.13 The main 
route of HCV infection is injection drug use (IDU), and IDU is likely to explain a 
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substantial proportion of the increased mortality in HCV 
infected patients. This hypothesis is supported by cause of 
death analyses among HCV infected patients.4,9,14 However, 
IDU is generally considered as unaccepted behavior lead-
ing to stigma, and therefore, IDU is often not disclosed in a 
patient–doctor relationship.15,16
Socioeconomic status (SES) refers to an individual’s 
position in society and may be based on criteria such as 
education, occupation, income, and value of dwelling 
place.17 Cross-sectional studies from the United States, 
Puerto Rico, Norway, and France have found associations 
between different SES markers and prevalence of HCV 
infection.18–22 The following markers of SES were tested: 
“receipt of beneficiaries of medical welfare for precarious 
persons”, “employment”, “education”, “stay in institutions 
or prisons”, “marital status”, “income” and “ethnicity”.18–22 
Even after adjusting for illicit drug use and other risk factors 
related to route of infection, these studies found an increased 
risk of HCV infection in persons with low SES.18,20–22 
However, these studies relied on surveys as the source 
of information on exposure, and as such were subjected to 
nondisclosure and recall bias.23 Thus far, no studies using a 
population based nationwide design based on established 
national registries have examined whether HCV infection 
is associated with SES at the individual level. Further, it 
remains important to clarify whether SES is associated 
with survival in HCV infected patients, as it is for patients 
with alcoholism,24 cancer,25,26 cardiovascular diseases27–30 
and cirrhosis.31
Thus, we undertook a population based study to investi-
gate markers of SES in HCV infected patients. We focused 
on occupational status, income, and educational status to 
address the following question: is low SES associated with 
an increased risk of HCV infection and a poor prognosis 
following infection?
Patients and methods
Substudy 1 – risk of HCV infection
This case control design addressed whether persons with 
low SES were at higher risk of HCV infection than persons 
with favorable SES (ie, employed persons with a personal 
income of 75% of the national average or higher, and with 
an educational level above basic schooling).
Substudy 2 – mortality after a diagnosis of HCV 
infection
This cohort design addressed whether low SES was associ-
ated with high mortality among HCV infected patients.
Setting
Denmark has a population of 5.4 million,32 with an estimated 
HCV prevalence of 0.4%.33 Most people in Denmark finish 
their higher education between the age of 25 and 30 years, 
but some would extend their education into their 30s. 
HCV infected patients are treated in hospital departments 
that specialize in infectious diseases, gastroenterology, or 
hepatology.34 Medical care, including antiviral treatment, is 
provided free of charge to all Danish residents. In 2000 to 
2001 approximately 5% of the workforce aged 40–59 years 
was unemployed.35
Data sources
We used the unique ten digit civil registration number 
assigned to all Danish residents36 to link individual level data 
from the following data sources.
Danish HCV cohort (DANVIR): HCV infected patients 
were identified from the DANVIR cohort, which comprises 
all patients tested for HCV in 14 of the 18 laboratories that 
perform such testing in Denmark.8,9 DANVIR data includes 
dates and results of HCV antibody tests (from 1991 onward) 
and HCV RNA tests (from 1995 onward). While HCV 
antibody tests are performed in all participating DANVIR 
centers, most HCV RNA measurements are done in the 
Department of Clinical Biochemistry, Aalborg University 
Hospital.37 When the DANVIR cohort was established, it was 
estimated to include more than 90% of all Danish patients 
tested for HCV RNA and the majority of patients tested for 
HCV antibodies.8,9,38
The Integrated Database for Labor Market Research 
(IDA): Occupational status and income were extracted 
from the IDA, which is maintained by Statistics Denmark 
and covers the entire population of Denmark.39 Data on 
income have been updated annually since 1980 and data 
on employment since 1994 for all tax eligible persons in 
Denmark.40,41 The main employment categories are “self-
employed,” “employed,” and “unemployed,” each with several 
subcategories.
The Educational Attainment Register (EAR): We 
extracted data on educational status from the EAR, which 
was established in 1974. This registry contains data 
on the  educational status of the entire Danish population.42 
The registry collects data from all educational institutions in 
the country, from elementary schools to universities, as well 
as parttime educational programs and educational programs 
outside of Denmark.
Civil Registration System (CRS): The CRS, which was 
established in 1968, maintains information on vital status 
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and migration for all Danish residents.36 We used this data 
source to identify a control group in substudy 1 and to obtain 
dates of death and migration.
Danish National Registry of Patients (DNRP): The DNRP, 
established in 1977, collects information on all nonpsychi-
atric hospital admissions in Denmark. Data from outpatient 
and emergency department visits were added in 1995. For 
each hospital contact, the DNRP records dates of admission 
and discharge, and up to 20 discharge diagnoses, assigned 
by physicians and coded according to the International Clas-
sification of Diseases, 8th revision (ICD-8)43 through 1993 
and the 10th version (ICD-10)44 from 1994 onwards.45 We 
extracted data from the DNRP on comorbidity and substance 
abuse, using diagnoses from inpatient hospitalizations, 
outpatient visits, and emergency room visits.8
The Registry of Drug Abusers Undergoing Treatment has 
registered all individuals in Denmark undergoing treatment 
for drug addiction since 1996.46 Treatment of drug addiction 
in Denmark is restricted to referral centers, which must sup-
ply data to the registry in order to obtain funding.
Study population
Substudy 1 – risk of HCV infection
In this case control design, cases were defined as HCV infected 
patients who (1) were registered in DANVIR with a  positive 
HCV antibody and/or HCV RNA test; (2) were born in 
 Denmark; (3) were aged between 40 and 60 years at diagnosis 
of HCV; (4) were registered in DANVIR with a diagnosis of 
HCV infection between January 1, 1999 and December 31, 
2006; and (5) had no previous diagnosis of HCV infection 
prior to January 1, 1999 in DANVIR or the DNRP (ICD-10 
codes B17.1 or 18.2). The age restriction was applied to select 
patients who had finished education. Patients with missing 
data on income or occupation (n = 8) were excluded. We used 
risk set sampling to identify the control group. For each HCV 
infected patient, we included five randomly selected individu-
als from the general population matched on age and sex.47
Substudy 2 – mortality after a diagnosis of HCV 
infection
Substudy 2, in which we analyzed the impact of SES on 
mortality, included only HCV infected patients.
Categorization of SES variables  
and covariates
SES
We used three indicators to measure SES in the calendar 
year preceding study inclusion: (1) primary occupation, 
(2) taxable personal income, and (3) educational attainment. 
We categorized study participants into one of three occu-
pational categories: employed persons (self-employed, 
executive or highly qualified employees, and employees with 
lower qualifications), unemployed persons (including those 
in educational programs), and persons receiving a disability 
pension. The disability pension, which is granted to persons 
with a permanent limitation in their ability to work,48,49 was 
used as an occupational category due to the unusually high 
number of HCV infected patients falling into this category. 
Income was categorized into three categories on the basis 
of taxable income: 0%–49%, 50%–74%, and .75% of 
the national average for persons of the same sex and age 
(in 5-year age categories). Education was computed as the 
highest level of education registered in the EAR, grouped into 
the following two categories: basic schooling (sixth grade) 
or higher education.
Substance abuse
We defined substance abuse as a diagnosis of alcohol abuse 
and/or IDU on or before the date of study inclusion. Alcohol 
abuse was defined as a record of one or more diagnoses 
suggesting alcohol abuse in the DNRP (see Supplementary 
material 1 for details). IDU was defined as inclusion in the 
Registry of Drug Abusers Undergoing Treatment and/or a 
record of one or more diagnoses suggesting IDU in the DNRP 
(see Supplementary material 1 for details).
Comorbidity
We calculated the Charlson Comorbidity Index (CCI) score 
derived from diagnoses registered in the DNRP before the index 
date.50,51 The positive predictive value of diagnosis coding in 
the DNRP for conditions included in the CCI is very high.52 
The CCI assigns a score between one and six to a range of 
diseases, with the sum of individual scores serving as a mea-
sure of patients’ overall comorbidity. We identified comorbid 
diseases using the ICD-10 codes provided by Quan et al53 
(matching ICD-8 codes to ICD-10 codes as closely as possible, 
see Supplementary material 2 for details). In the present study, 
liver diseases were regarded as complications in the causal path-
way of HCV infection and were therefore not included in the 
CCI. We used three comorbidity levels: none (CCI score = 0), 
medium (CCI score = 1–2), and high (CCI score . 2).
Statistical analysis
Substudy 1 – risk of HCV infection
Analyses focused on employment, income, and  education, 
as defined above for the calendar year preceding the 
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HCV diagnosis. We used conditional logistic regression to 
obtain odds ratios (ORs) for HCV infection for each of the 
three SES markers, adjusting for the other two SES  markers, 
comorbidity level, and substance abuse.54 Because HCV 
infection often precedes HCV diagnosis by several years 
due to the subclinical nature of the acute infection, low SES 
could be a consequence of HCV infection. For this reason, we 
reran the conditional logistic regression model replacing SES 
status during the year before HCV diagnosis with SES status 
7 years before diagnosis. Because this yielded essentially the 
same results, we retained the SES variable values for the year 
before HCV diagnosis in the final model.
Substudy 2 – mortality after a diagnosis of HCV 
infection
In substudy 2, HCV infected patients were followed from the 
date of HCV diagnosis to death, emigration, or  January 1, 
2010, whichever came first. Patients were censored in 
the  survival analyses in case they emigrated as we could 
no longer keep track of them by use of the Danish national 
registries. The study outcome was survival time. Analyses 
were based on three SES markers for the calendar year 
preceding the HCV diagnosis: employment, income, and 
education, as defined above. We used Cox proportional 
 hazards regression to compute hazard ratios as an estimate 
for mortality rate ratios (MRR) for each level of each of the 
three SES markers, adjusting for the other two markers, as 
well as for comorbidity level, age at HCV infection, substance 
abuse (yes/no), and gender. Using Schoenfeld residuals, we 
determined that the hazard ratios were constant over the 
follow-up time.
We computed survival probabilities using the Kaplan–
Meier method, illustrating survival in each of the nine 
categories defined by the combination of the three employ-
ment categories and the three income categories. We did 
not illustrate survival according to educational status, as the 
initial analysis demonstrated that educational status was not 
associated with survival.
Approvals and permissions
The Danish Data Protection Agency approved the study 
(record no 2007-41-0775).
Results
Characteristics of HCV infected patients 
and controls
We identified 3016 Danish HCV infected patients (Table 1). 
Of these, 1991 (66.0%) were male and the median age was 
Table 1 Characteristics of the 3016 hepatitis C virus (HCV) 
infected patients and the 15,080 controls
HCV infected  
patients
Controls
Number Percent  
of total
Number Percent 
of total
Total 3016 100 15,080 100
Male 1991 66.0 9955 66.0
Income in percent of national average*
 0%–49% 1512 50.1 1774 11.7
 50%–74% 755 25.0 3017 20.0
 .75% 749 24.8 10,289 68.2
Employment
 Employed 939 31.1 12,659 83.9
  Unemployed/ 
seeking education
691 22.9 1231 8.2
  Disability  
pensioner
1386 46.0 1190 7.9
Education
  Basic schooling  
(sixth grade)
1830 60.7 4396 29.2
 Higher education 1186 39.3 10,684 70.8
Comorbidity
 None (score = 0) 2248 74.5 13,335 88.4
  Medium  
(score = 1–2)
554 18.4 1521 10.1
 High (score $2) 214 7.1 224 1.5
Substance abuse
 No 1348 44.7 14,718 97.6
 Yes 1668 55.3 362 2.4
  Alcohol abuse 220 7.3 261 1.7
  Drug abuse 1135 37.6 66 0.4
   Drug and  
alcohol abuse
313 10.4 35 0.2
Note: *For same sex and age (in 5-year categories).
47 years (interquartile range = 44–51 years). When com-
pared with the 15,080 population controls, HCV infected 
patients were more likely to have an income below 50% of 
the national average (50.1% versus 11.7%), to be disability 
pensioners (46.0% versus 7.9%), to have completed only 
basic schooling (60.7% versus 29.2%), to have comorbidity 
(25.5% versus 11.6%), and to have substance abuse (55.3% 
versus 2.4%) (Table 1).
Substudy 1 – risk of HCV infection
All three SES markers were associated with risk of HCV 
infection (Figure 1). When compared to employed per-
sons, disability pensioners had a 2.71 fold increased risk 
of diagnosis with HCV infection (95% confidence interval 
[CI]: 2.24–3.26), and unemployed persons had a 2.24 fold 
increased risk (95% CI: 1.83–2.72). When compared to 
those with a high income (.75% of the national average), 
those with a low income (0%–49% of the national average) 
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Figure 1 Odds ratios for being diagnosed with hepatitis C virus according to employment, income, and educational level.
Note: Odds ratios for each variable are adjusted for the other variables in the figure.
Abbreviations: CCI, Charlson Comorbidity Index; CI, confidence intervals; OR, odds ratio.
had a 1.64 fold increased risk of HCV infection (95% CI: 
1.34–2.01), while those with a medium income (50%–74% 
of the national average) had a 1.19 fold increased risk (95% 
CI: 1.02–1.40). Having a low education (basic schooling to 
sixth grade level) was associated with a 1.35 fold increased 
risk of HCV infection (95% CI: 1.20–1.52), when compared 
with attainment of higher education.
Substudy 2 – mortality after a diagnosis 
of HCV infection
When compared to employed patients, mortality was 
increased among unemployed patients (MRR: 1.71, 95% CI: 
1.22–2.40) and disability pensioners (MRR: 2.24, 95% CI: 
1.63–3.08). Regardless of income, employed patients had 
a higher 8-year survival rate than unemployed patients and 
those with a disability pension. Unemployed patients had a 
higher 8-year survival rate than patients receiving disability 
pensions (Figure 2).
Income also was associated with mortality. When com-
pared to patients with an income at or above 75% of the 
national average, mortality was higher in patients with an 
income between 50% and 74% of the national average (MRR: 
1.47, 95% CI: 1.05–2.05) and in patients with an income 
between 0% and 49% of the national average (MRR: 1.64, 
95% CI: 1.13–2.34). Generally, patients in the highest income 
category had a higher 8-year survival rate than patients in the 
middle and lowest income categories (Figure 3). Educational 
status was not associated with prognosis. The MRR was 1.01 
(95% CI: 0.86–1.18).
Discussion
In this combined population based case control and cohort 
study, we have shown that low SES is associated with an 
increased risk of HCV infection, and that once infected, 
patients with low SES have higher mortality.
The study strengths were inclusion of nearly all Danes 
testing positive for HCV infection, as well as having a long 
and complete follow-up. Use of routinely collected nation-
wide administrative data on SES and hospitalization history 
ensured that high quality data were collected independently 
of our study. This further reduced the risk of bias due to dif-
ferences in data validity.
The main limitation of our study was its reliance on 
national registries to capture substance abuse. Our clinical 
experience indicates that most HCV infected patients are, 
or have been, IDUs. Yet, in our study only 50% of patients 
were registered as IDUs. Of the remaining 50% not  registered 
as IDUs, we speculate that the majority are in fact also 
IDUs and thereby misclassified.55 The National Board of 
Health has estimated that only 33%–50% of the supposed 
13,000 IDUs are registered in The Registry of Drug Abusers 
Undergoing Treatment.56 Although these figures are not 
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risk of HCV infection in patients with low SES.18,20–22 Our 
study adds validity to these findings by producing essentially 
the same results using data from national registries instead 
of surveys. The mechanism underlying the increased risk 
of HCV infection among patients with low SES is poorly 
understood.22 It is possible that undocumented IDU in per-
sons with low SES could explain the association.20 Also, low 
SES could be a consequence of HCV infection, since HCV 
infection often precedes diagnosis by several years due to 
the subclinical nature of the acute infection. However, our 
analysis has shown that SES did not change substantially up 
to 7 years before HCV diagnosis, and the associations did not 
change when we focused on SES markers measured 7 years 
before HCV diagnosis (data not shown).
Even in the absence of a causal relation between low SES 
and HCV infection, and despite concerns of the temporal 
relationship between SES and HCV infection, our study has 
clinical and public health implications. In the absence of a 
known history of IDU or other high risk behaviors, a test 
for HCV infection should be performed if this infection is 
suspected, especially in patients with low SES, as low SES 
could be a marker of undisclosed IDU. We suggest that low 
SES be considered along with other risk factors to define the 
target population for future HCV screening campaigns.
SES has been studied previously as a prognostic marker 
for several diseases, but not for HCV infected patients. 
 Employment has been associated with prognosis among cir-
rhosis patients, with disability pensioners at particularly high 
risk of death.31 Among Danish cancer patients, receipt of a 
disability pension and low income was associated with poor 
prognosis, especially for short-term survival.25 Educational 
status was not associated with survival in our study. This 
contrasts with a recent study by Ly et al demonstrating that 
an educational level of “starting college or more” when 
compared to “less than high school” was protective of dying 
from HCV infection.57 In a study of liver transplantation 
recipients with HCV infection, SES was not associated with 
mortality or the composite endpoint “death or graft loss due to 
HCV”.58 It is not clear why SES is associated with mortality 
in some settings but not in others, and why different studies 
find varying markers of SES associated with prognosis. 
It may be hypothesized that socioeconomic inequalities in 
mortality could be explained by material, behavioral, and 
psychosocial factors, with behavioral factors in particular 
(smoking above 20 cigarettes per day and excessive alcohol 
intake) being strongly associated with mortality.59 Observed 
effects of employment and income on prognosis could be 
an indirect measure of alcohol abuse, smoking, IDU, and 
5
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Figure 2 The association between socioeconomic status and survival in hepatitis 
C virus infected patients.
Note: Associations are expressed as mortality rate ratios, with associated 95% 
confidence intervals. Mortality rate ratios for each variable are adjusted for the 
other variables in the figure.
Abbreviations: CCI, Charlson Comorbidity Index; CI, confidence intervals; 
MMR, mortality rate ratio.
directly comparable, they indicate that a large proportion of 
IDUs are not registered in national registries. We also missed 
cases of alcohol abuse not leading to hospital contacts and 
therefore not recorded in the DNRP. Furthermore, because 
of our reliance on national registries, we were unable to 
distinguish former from current substance abusers. We were 
also unable to quantify the level of substance abuse (alcohol 
and IDU). Another concern is that we included HCV RNA 
positive and/or HCV antibody positive patients. Some of the 
HCV antibody positive patients have cleared their infections. 
While clearance is associated with improved survival,8 it is 
unlikely that the effect of SES differs according to whether 
or not the infection was cleared. Finally, we lacked data on 
antiviral treatment and liver transplantation, so we could not 
address issues of compliance with these interventions and 
their effects.
Our finding that low SES is associated with increased risk 
of HCV infection is consistent with cross-sectional studies 
from United States, Puerto Rico, Norway, and France, which 
found associations between various SES markers and preva-
lence of HCV infection.18–22 As expected, IDU was consis-
tently and strongly associated with HCV infection. Even after 
adjusting for illicit drug use, these studies found an increased 
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unknown risk taking behaviors not captured in our study. 
We speculate that HCV infected patients who are disability 
pensioners are less likely to receive antiviral treatment, may 
receive inferior treatment, or be less compliant with treatment 
than more affluent patients. However, it has been estimated 
that only 2% of Danish HCV infected patients have been 
treated with interferon,60 and therefore we find it unlikely 
that the results are substantially confounded by missing 
data on antiviral treatment. Noncompliant individuals may 
be less likely to be candidates for liver transplantation, if 
otherwise indicated. Whatever the underlying mechanisms 
are, low income HCV infected patients and those receiving 
disability pensions may benefit from more frequent follow-up 
visits to ensure treatment compliance and surveillance for 
hepatocellular carcinoma. To further address alcohol abuse, 
IDU and comorbidities may reduce increased mortality 
among these patients.
In conclusion, we found that low SES was associated 
with increased risk of HCV infection, possibly explained by 
undisclosed IDU. Furthermore, low SES was associated 
with a poor prognosis in HCV infected patients, with those 
receiving a disability pension at particularly elevated risk of 
death when compared to employed patients.
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Table S1 Coding algorithm used for comorbid conditions in the Charlson Comorbidity Index
Comorbid condition in CCI ICD-8 ICD-10 Score
Myocardial infarction 410 I21, 122, I23 1
Congestive heart failure 427.09, 427.10, 427.11, 427.19, 428.99,  
782.49
I50, I11.0, I13.0, I13.2 1
Peripheral vascular disease 440–445 I70–I74, I77 1
Cerebrovascular disease 430–438 I60–I69, G45, G46 1
Dementia 290.09–290.19, 293.09 F00–F03, F05.1, G30 1
Chronic pulmonary disease 490–493, 515–518 J40–J47, J60–J67, J68.4, J70.1, J70.3, J84.1, J92.0,  
J96.1, J98.2, J98.3
1
Connective tissue disease 712, 716, 734, 446, 139.99 M05, M06, M08, M09, M30–M36, D86 1
Ulcer disease 530.91, 530.98, 531–534 K22.1, K25–K28 1
Diabetes mellitus type 1 and 2 249.00, 249.06, 249.07, 249.09,  
250.00, 250.06, 250.07, 250.09
E10.0, E10.1, E10.9, E11.0, E11.1, E11.9 1
Hemiplegia 344 G81, G82 2
Moderate to severe renal disease 403, 404, 580–584, 590.09, 593.19,  
753.10–753.19, 792
I12, I13, N00–N05, N07, N11, N14,  
N17–N19, Q61
2
Diabetes mellitus type 1 and 2 with  
end organ damage
249.01–249.05, 249.08, 250.01–250.05,  
250.08
E10.2–E10.8, E11.2–E11.8 2
Any tumor 140–194 C00–C75 2
Leukemia 204–207 C91–C95 2
Lymphoma 200–203 C81–C85, C88, C90, C96 2
Metastatic solid tumor 195–199 C76–C80 6
AIDS 79.83 B21–B24 6
Mild liver disease* 571, 573.01, 573.04 B18, K70.0–K70.3, K70.9, K71, K73, K74, K76.0 1
Moderate to severe liver disease* 70.00, 70.02, 70.04, 70.06, 70.08, 573.00, 456 B15.0, B16.0, B16.2, B19.0, K70.4, K72, K76.6, I85 3
Note: *The liver diseases of the CCI were not included in our comorbidity score, as they were considered as being part of the causal pathway of mortality.
Abbreviations: CCI, Charlson Comorbidity Index; ICD, International Classification of Diseases.
Supplementary Materials
Supplementary material 1
Definitions of alcohol abuse  
and injection drug use (IDU)
Alcohol abuse
A record in Danish National Registry of Patients of 
International Classification of Diseases (ICD)-8 codes: 
291.00–291.99, 571.09, 571.10, 303.00–89, and 303.91–99 
and ICD-10 codes: K70.0–K70.9, F10.2–F10.9, and G31.2 
before study inclusion.
IDU
A record in Danish National Registry of Patients of ICD-8 
codes: 304.09–304.99 and ICD-10 codes: F11.0–F19.9, 
T40.0–T40.9, and/or registration in The Registry of Drug 
Abusers Undergoing Treatment before study inclusion.
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